For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

Guest Dr. John Gore and host Dr. Davide Soldato discuss JCO article, "12-Month Results from the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent Non-Muscle ...

The recommendations were developed by a multidisciplinary task force and are based on a systematic review of literature ...

Findings may establish a framework for assisting patient counselling and optimizing therapy selection for those undergoing radical cystectomy. Sequencing pelvic radiotherapy before radical cystectomy ...

—A retrospective real-world study of patients with muscle-invasive bladder cancer showed that robot-assisted and laparoscopic radical cystectomy reduce post-surgical complication rates, compared to ...

RARC with intracorporeal urinary diversion offers survival outcomes similar to those of open radical cystectomy, but is associated with better perioperative outcomes. Real-world data support the ...

Partial cystectomy for muscle-invasive bladder cancer offers metastasis- and cancer-free survival comparable to that of radical cystectomy, but with less perioperative morbidity. Partial and radical ...

AstraZeneca?s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) in combination with enfortumab vedotin (EV) was accepted and granted Priority Review in the US for the ...

The FDA grants priority review to applications for drugs that, if approved, would offer significant improvements over ...